Skip to main content

Surgery for Solid Pancreatic Neoplasms

  • Chapter
Pancreatic Masses

Abstract

Pancreatic surgery for malignancy can be broadly classified into curative or palliative surgery. Every attempt is made to devise a decision preoperatively; however, despite the best imaging currently available, locally advanced or metastatic disease is found in 15–20 % on exploration for a curative intent.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Callery MP, Chang KJ, Fishman EK, Talamonti MS, William Traverso L, Linehan DC. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol. 2009;16(7):1727–33.

    Article  PubMed  Google Scholar 

  2. John TG, Greig JD, Carter DC, Garden OJ. Carcinoma of the pancreatic head and periampullary region: tumor staging with laparoscopy and laparoscopic ultrasonography. Ann Surg. 1995;221(2):156–64.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Liu RC, Traverso LW. Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography. Surg Endosc. 2005;19(5):638–42.

    Article  CAS  PubMed  Google Scholar 

  4. Thomson BNJ, Parks RW, Redhead DN, et al. Refining the role of laparoscopy and laparoscopic ultrasound in the staging of presumed pancreatic head and ampullary tumours. Br J Cancer. 2006;94(2):213–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Mayo SC, Austin DF, Sheppard BC, Mori M, Shipley DK, Billingsley KG. Evolving preoperative evaluation of patients with pancreatic cancer: does laparoscopy have a role in the current era? J Am Coll Surg. 2009;208(1):87–95.

    Article  PubMed  Google Scholar 

  6. Pisters PWT, Lee JE, Vauthey JN, Charnsangavej C, Evans DB. Laparoscopy in the staging of pancreatic cancer. Br J Surg. 2001;88(3):325–37.

    Article  CAS  PubMed  Google Scholar 

  7. Sosa JA, Bowman HM, Gordon TA, et al. Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg. 1998;228(3):429–38.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998;280(20):1747–51.

    Article  CAS  PubMed  Google Scholar 

  9. Bliss LA, Yang CJ, Chau Z, et al. Patient selection and the volume effect in pancreatic surgery: unequal benefits? HPB. 2014;16:899–906.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Lieberman MD, Kilburn H, Lindsey M, Brennan MF. Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg. 1995;222(5):638–45.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Rosemurgy A, Cowgill S, Coe B, et al. Frequency with which surgeons undertake pancreaticoduodenectomy continues to determine length of stay, hospital charges, and in-hospital mortality. J Gastrointest Surg. 2008;12(3):442–9.

    Article  PubMed  Google Scholar 

  12. Rosemurgy AS, Bloomston M, Serafini FM, Coon B, Murr MM, Carey LC. Frequency with which surgeons undertake pancreaticoduodenectomy determines length of stay, hospital charges, and in-hospital mortality. J Gastrointest Surg. 2001;5(1):21–6.

    Article  CAS  PubMed  Google Scholar 

  13. Birkmeyer JD, Finlayson SRG, Tosteson ANA, Sharp SM, Warshaw AL, Fisher ES. Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy. Surgery. 1999;125(3):250–6.

    Article  CAS  PubMed  Google Scholar 

  14. Birkmeyer JD, Siewers AE, Finlayson EVA, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15):1128–37.

    Article  PubMed  Google Scholar 

  15. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003;349(22):2117–27.

    Article  CAS  PubMed  Google Scholar 

  16. Bilimoria KY, Talamonti MS, Sener SF, et al. Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer. J Am Coll Surg. 2008;207(4):510–9.

    Article  PubMed  Google Scholar 

  17. Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006;10(9):1199–211.

    Article  PubMed  Google Scholar 

  18. Farnell MB, Pearson RK, Sarr MG, et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery. 2005;138(4):618–30.

    Article  PubMed  Google Scholar 

  19. Yeo CJ, Cameron JL, Sohn TA, et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg. 1999;229(5):613–24.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002;236(3):355–68.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Michalski CW, Kleeff J, Wente MN, Diener MK, Büchler MW, Friess H. Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg. 2007;94(3):265–73.

    Article  CAS  PubMed  Google Scholar 

  22. Iqbal N, Lovegrove RE, Tilney HS, et al. A comparison of pancreaticoduodenectomy with extended pancreaticoduodenectomy: a meta-analysis of 1909 patients. Eur J Surg Oncol. 2009;35(1):79–86.

    Article  CAS  PubMed  Google Scholar 

  23. Grobmyer SR, Kooby D, Blumgart LH, Hochwald SN. Novel pancreaticojejunostomy with a low rate of anastomotic failure-related complications. J Am Coll Surg. 2010;210(1):54–9.

    Article  PubMed  Google Scholar 

  24. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138(1):8–13.

    Article  PubMed  Google Scholar 

  25. Butturini G, Daskalaki D, Molinari E, Scopelliti F, Casarotto A, Bassi C. Pancreatic fistula: definition and current problems. J Hepatobiliary Pancreat Surg. 2008;15(3):247–51.

    Article  PubMed  Google Scholar 

  26. Bassi C, Falconi M, Salvia R, Caldiron E, Butturini G, Pederzoli P. Role of octreotide in the treatment of external pancreatic pure fistulas: a single-institution prospective experience. Langenbecks Arch Surg. 2000;385(1):10–3.

    Article  CAS  PubMed  Google Scholar 

  27. Lai ECH, Lau SHY, Lau WY. Measures to prevent pancreatic fistula after pancreatoduodenectomy: a comprehensive review. Arch Surg. 2009;144(11):1074–80.

    Article  PubMed  Google Scholar 

  28. Buchler MW, Wagner M, Schmied BM, Uhl W, Friess H, Z’graggen K. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg. 2003;138(12):1310–4; discussion 1315.

    Article  PubMed  Google Scholar 

  29. Berberat PO, Friess H, Kleeff J, Uhl W, Büchler MW. Prevention and treatment of complications in pancreatic cancer surgery. Dig Surg. 1999;16(4):327–36.

    Article  CAS  PubMed  Google Scholar 

  30. Halloran CM, Ghaneh P, Bosonnet L, Hartley MN, Sutton R, Neoptolemos JP. Complications of pancreatic cancer resection. Dig Surg. 2002;19(2):138–46.

    Article  CAS  PubMed  Google Scholar 

  31. Cullen JJ, Sarr MG, Ilstrup DM. Pancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management. Am J Surg. 1994;168(4):295–8.

    Article  CAS  PubMed  Google Scholar 

  32. Torres AJ, Landa JI, Moreno-Azcoita M, et al. Somatostatin in the management of gastrointestinal fistulas: a multicenter trial. Arch Surg. 1992;127(1):97–100.

    Article  CAS  PubMed  Google Scholar 

  33. Nubiola P, Badia JM, Martinez-Rodenas F, et al. Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201-995. Ann Surg. 1989;210(1):56–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Alvarez C, McFadden DW, Reber HA. Complicated enterocutaneous fistulas: failure of octreotide to improve healing. World J Surg. 2000;24(5):533–7; discussion 538.

    Article  CAS  PubMed  Google Scholar 

  35. Connor S, Alexakis N, Garden OJ, Leandros E, Bramis J, Wigmore SJ. Meta-analysis of the value of somatostatin and its analogues in reducing complications associated with pancreatic surgery. Br J Surg. 2005;92(9):1059–67.

    Article  CAS  PubMed  Google Scholar 

  36. Zeng Q, Zhang Q, Han S, et al. Efficacy of somatostatin and its analogues in prevention of postoperative complications after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials. Pancreas. 2008;36(1):18–25.

    Article  CAS  PubMed  Google Scholar 

  37. Hesse UJ, DeDecker C, Houtmeyers P, et al. Prospectively randomized trial using perioperative low-dose octreotide to prevent organ-related and general complications after pancreatic surgery and pancreatico-jejunostomy. World J Surg. 2005;29(10):1325–8.

    Article  PubMed  Google Scholar 

  38. Alghamdi AA, Jawas AM, Hart RS. Use of octreotide for the prevention of pancreatic fistula after elective pancreatic surgery: a systematic review and meta-analysis. Can J Surg. 2007;50(6):459–66.

    PubMed Central  PubMed  Google Scholar 

  39. Shan YS, Sy ED, Tsai ML, Tang LY, Li PS, Lin PW. Effects of somatostatin prophylaxis after pylorus-preserving pancreaticoduodenectomy: increased delayed gastric emptying and reduced plasma motilin. World J Surg. 2005;29(10):1319–24.

    Article  PubMed  Google Scholar 

  40. Ramos-De la Medina A, Sarr MG. Somatostatin analogues in the prevention of pancreas-related complications after pancreatic resection. J Hepatobiliary Pancreat Surg. 2006;13(3):190–3.

    Article  PubMed  Google Scholar 

  41. Suc B, Msika S, Piccinini M, et al. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial. Arch Surg. 2004;139(3):288–94; discussion 295.

    Article  PubMed  Google Scholar 

  42. Sarr MG, Pancreatic Surgery Group. The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial. J Am Coll Surg. 2003;196(4):556–64; discussion 564–5; author reply 565.

    Article  PubMed  Google Scholar 

  43. Allen PJ, Gonen M, Brennan MF, et al. Pasireotide for postoperative pancreatic fistula. N Engl J Med. 2014;370(21):2014–22.

    Article  PubMed  Google Scholar 

  44. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg. 1995;221(6):721–31; discussion 731–3.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Adam U, Makowiec F, Riediger H, Schareck WD, Benz S, Hopt UT. Risk factors for complications after pancreatic head resection. Am J Surg. 2004;187(2):201–8.

    Article  PubMed  Google Scholar 

  46. Wente MN, Veit JA, Bassi C, et al. Postpancreatectomy hemorrhage (PPH)—an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. 2007;142(1):20–5.

    Article  PubMed  Google Scholar 

  47. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997;226(3):248–57; discussion 257–60.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  48. Schafer M, Mullhaupt B, Clavien PA. Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg. 2002;236(2):137–48.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007;142(5):761–8.

    Article  PubMed  Google Scholar 

  50. Horstmann O, Markus PM, Ghadimi MB, Becker H. Pylorus preservation has no impact on delayed gastric emptying after pancreatic head resection. Pancreas. 2004;28(1):69–74.

    Article  PubMed  Google Scholar 

  51. van Berge Henegouwen MI, van Gulik TM, DeWit LT, et al. Delayed gastric emptying after standard pancreaticoduodenectomy versus pylorus-preserving pancreaticoduodenectomy: an analysis of 200 consecutive patients. J Am Coll Surg. 1997;185(4):373–9.

    Article  PubMed  Google Scholar 

  52. Jimenez RE, Fernandez-del Castillo C, Rattner DW, Chang Y, Warshaw AL. Outcome of pancreaticoduodenectomy with pylorus preservation or with antrectomy in the treatment of chronic pancreatitis. Ann Surg. 2000;231(3):293–300.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  53. Roder JD, Stein HJ, Huttl W, Siewert JR. Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg. 1992;79(2):152–5.

    Article  CAS  PubMed  Google Scholar 

  54. Di Carlo V, Zerbi A, Balzano G, Corso V. Pylorus-preserving pancreaticoduodenectomy versus conventional Whipple operation. World J Surg. 1999;23(9):920–5.

    Article  PubMed  Google Scholar 

  55. Mosca F, Giulianotti PC, Balestracci T, et al. Long-term survival in pancreatic cancer: pylorus-preserving versus Whipple pancreatoduodenectomy. Surgery. 1997;122(3):553–66.

    Article  CAS  PubMed  Google Scholar 

  56. Lin PW, Lin YJ. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg. 1999;86(5):603–7.

    Article  CAS  PubMed  Google Scholar 

  57. Yeo CJ, Barry MK, Sauter PK, et al. Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial. Ann Surg. 1993;218(3):229–37; discussion 237–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  58. Hochwald SN, Grobmyer SR, Hemming AW, et al. Braun enteroenterostomy is associated with reduced delayed gastric emptying and early resumption of oral feeding following pancreaticoduodenectomy. J Surg Oncol. 2010;101(5):351–5.

    PubMed  Google Scholar 

  59. Kleeff J, Diener MK, Z’graggen K, et al. Distal pancreatectomy: risk factors for surgical failure in 302 consecutive cases. Ann Surg. 2007;245(4):573–82.

    Article  PubMed Central  PubMed  Google Scholar 

  60. Strasberg SM, Drebin JA, Linehan D. Radical antegrade modular pancreatosplenectomy. Surgery. 2003;133(5):521–7.

    Article  PubMed  Google Scholar 

  61. Shoup M, Brennan MF, McWhite K, Leung DHY, Klimstra D, Conlon KC. The value of splenic preservation with distal pancreatectomy. Arch Surg. 2002;137(2):164–8.

    Article  PubMed  Google Scholar 

  62. Warshaw AL. Conservation of the spleen with distal pancreatectomy. Arch Surg. 1988;123(5):550–3.

    Article  CAS  PubMed  Google Scholar 

  63. Fahy BN, Frey CF, Ho HS, Beckett L, Bold RJ. Morbidity, mortality, and technical factors of distal pancreatectomy. Am J Surg. 2002;183(3):237–41.

    Article  PubMed  Google Scholar 

  64. Fernandez-del Castillo C, Rattner DW, Warshaw AL. Standards for pancreatic resection in the 1990s. Arch Surg. 1995;130(3):295–9; discussion 299–300.

    Article  CAS  PubMed  Google Scholar 

  65. Sheehan MK, Beck K, Creech S, Pickleman J, Aranha GV. Distal pancreatectomy: does the method of closure influence fistula formation? Am Surg. 2002;68(3):264–7; discussion 267–8.

    PubMed  Google Scholar 

  66. Hamilton NA, Porembka MR, Johnston FM, et al. Mesh reinforcement of pancreatic transection decreases incidence of pancreatic occlusion failure for left pancreatectomy: a single-blinded, randomized controlled trial. Ann Surg. 2012;255(6):1037–42.

    Article  PubMed Central  PubMed  Google Scholar 

  67. Efron DT, Lillemoe KD, Cameron JL, Yeo CJ. Central pancreatectomy with pancreaticogastrostomy for benign pancreatic pathology. J Gastrointest Surg. 2004;8(5):532–8.

    Article  PubMed  Google Scholar 

  68. Karpoff HM, Klimstra DS, Brennan MF, Conlon KC. Results of total pancreatectomy for adenocarcinoma of the pancreas. Arch Surg. 2001;136(1):44–7; discussion 48.

    Article  CAS  PubMed  Google Scholar 

  69. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg. 2004;91(5):586–94.

    Article  CAS  PubMed  Google Scholar 

  70. Ammori BJ, Ayiomamitis GD. Laparoscopic pancreaticoduodenectomy and distal pancreatectomy: a UK experience and a systematic review of the literature. Surg Endosc. 2011;25(7):2084–99.

    Article  PubMed  Google Scholar 

  71. Kendrick ML, Cusati D. Total laparoscopic pancreaticoduodenectomy: feasibility and outcome in an early experience. Arch Surg. 2010;145(1):19–23.

    Article  PubMed  Google Scholar 

  72. Cuschieri A, Jakimowicz JJ, van Spreeuwel J. Laparoscopic distal 70% pancreatectomy and splenectomy for chronic pancreatitis. Ann Surg. 1996;223(3):280–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  73. Gagner M, Pomp A. Laparoscopic pylorus-preserving pancreatoduodenectomy. Surg Endosc. 1994;8(5):408–10.

    Article  CAS  PubMed  Google Scholar 

  74. Nakamura M, Nakashima H. Laparoscopic distal pancreatectomy and pancreatoduodenectomy: is it worthwhile? A meta-analysis of laparoscopic pancreatectomy. J Hepatobiliary Pancreat Sci. 2013;20(4):421–8.

    Article  PubMed  Google Scholar 

  75. Venkat R, Edil BH, Schulick RD, Lidor AO, Makary MA, Wolfgang CL. Laparoscopic distal pancreatectomy is associated with significantly less overall morbidity compared to the open technique: a systematic review and meta-analysis. Ann Surg. 2012;255(6):1048–59.

    Article  PubMed  Google Scholar 

  76. Jin T, Altaf K, Xiong JJ, et al. A systematic review and meta-analysis of studies comparing laparoscopic and open distal pancreatectomy. HPB (Oxford). 2012;14(11):711–24.

    Article  Google Scholar 

  77. Magge D, Gooding W, Choudry H, et al. Comparative effectiveness of minimally invasive and open distal pancreatectomy for ductal adenocarcinoma. JAMA Surg. 2013;148(6):525–31.

    Article  PubMed  Google Scholar 

  78. Tran Cao HS, Lopez N, Chang DC, et al. Improved perioperative outcomes with minimally invasive distal pancreatectomy: results from a population-based analysis. JAMA Surg. 2014;149(3):237–43.

    Article  PubMed  Google Scholar 

  79. Cirocchi R, Partelli S, Coratti A, Desiderio J, Parisi A, Falconi M. Current status of robotic distal pancreatectomy: a systematic review. Surg Oncol. 2013;22(3):201–7.

    Article  PubMed  Google Scholar 

  80. Giulianotti PC, Sbrana F, Bianco FM, et al. Robot-assisted laparoscopic pancreatic surgery: single-surgeon experience. Surg Endosc. 2010;24(7):1646–57.

    Article  PubMed  Google Scholar 

  81. Zureikat AH, Moser AJ, Boone BA, Bartlett DL, Zenati M, Zeh III HJ. 250 robotic pancreatic resections: safety and feasibility. Ann Surg. 2013;258(4):554–9; discussion 559–62.

    PubMed Central  PubMed  Google Scholar 

  82. Van Heek NT, De Castro SM, van Eijck CH, et al. The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg. 2003;238(6):894–902; discussion 902–5.

    Article  PubMed Central  PubMed  Google Scholar 

  83. Lillemoe KD, Cameron JL, Hardacre JM, et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg. 1999;230(3):322–8; discussion 328–30.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  84. Espat NJ, Brennan MF, Conlon KC. Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass. J Am Coll Surg. 1999;188(6):649–55; discussion 655–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven N. Hochwald M.D., F.A.C.S. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Kukar, M., Hochwald, S.N. (2016). Surgery for Solid Pancreatic Neoplasms. In: Wagh, M., Draganov, P. (eds) Pancreatic Masses. Springer, Cham. https://doi.org/10.1007/978-3-319-19677-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-19677-0_17

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-19676-3

  • Online ISBN: 978-3-319-19677-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics